首页 > 市场调查报告书 > 製药

基因治疗学和RNAi

市场调查报告书

商品编码

1863871

基因表现市场按产品类型、应用、技术、工作流程步骤、样本类型、最终用户和地区划分

Gene Expression Market, By Product Type, By Application, By Technology, By Workflow Stage, By Sample Type, By End User, By Geography

出版日期: 2025年10月22日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格

简介目录

基因表现市场预计到 2025 年价值 165.6 亿美元，预计到 2032 年将达到 236.1 亿美元，2025 年至 2032 年的复合年增长率为 5.2%。

报告范围		报告详情
基准年：	2024	2025年市场规模：	165.6亿美元
性能数据：	2020年至2024年	预测期：	2025年至2032年
预测期（2025-2032年）复合年增长率：	5.20%	2032 年价值预测：	236.1亿美元

基因表现是生物学中的一个基本过程，透过这个过程，DNA中编码的遗传讯息转化为功能性蛋白质，驱动细胞活动并决定生物体的特征。全球基因表现市场涵盖了一系列技术、试剂、仪器和服务，旨在分析、量化和理解各种生物系统中的基因活性模式。这个快速发展的市场包括先进的分析平台，例如RNA定序、微阵列、定量PCR和次世代定序技术，使研究人员能够解析复杂的基因调控机制。

该市场服务于多种应用领域，包括基础研究、药物发现与开发、个人化医疗、农业生物技术和临床诊断。随着基因组研究投入的不断增加、遗传疾病盛行率的上升以及精准医疗方法日益受到关注，基因表现市场已成为推动科学认知和治疗性介入的关键力量。人工智慧 (AI) 和机器学习演算法与基因表现分析平台的融合，进一步革新了数据解读能力，使研究人员能够从海量基因组数据集中提取有意义的信息，并加速生命科学领域的突破性发现。

市场动态

全球基因表现市场受多种关键因素驱动，这些因素正在从根本上改变分子生物学研究和临床应用的模式。全球政府机构和私人组织对基因组研究经费的指数级增长是主要催化剂，使研究人员能够投资先进的基因表现分析技术并扩展其研究能力。癌症、遗传性疾病和复杂疾病的日益普遍，使得人们需要进行全面的基因表现分析，以了解疾病机制并开发标靶治疗，这显着推动了对先进分析平台的需求。

个人化医疗方法的日益普及，即根据个别基因谱客製化治疗方案，显着提高了临床对精准基因表现分析的需求。此外，次世代定序、RNA定序和高通量筛检平台等技术的进步，提高了分析精度并降低了营运成本，使基因表现分析更容易被科研机构和医疗机构所采用。然而，目前仍存在显着的市场限制。先进的基因表现分析仪器需要大量的资金投入，这可能会限制其在新兴市场小型研究机构和组织中的应用。此外，数据解读的复杂性以及对专业生物资讯学知识的需求，也为缺乏足够技术资源和熟练人员的机构带来了障碍。

临床应用的监管合规要求和漫长的核准流程可能会延缓市场渗透，并增加市场参与企业的研发成本。儘管面临这些挑战，基因表现分析在农业生物技术、环境监测和工业生物技术领域的日益广泛的应用也带来了巨大的机会。人工智慧 (AI) 和机器学习演算法的日益融合，为开发更先进的分析平台创造了机会，这些平台能够处理复杂的基因组数据集，并为研究人员和临床医生提供可操作的见解。

本次调查的主要特点

本报告对全球基因表现市场进行了详细分析，以 2024 年为基准年，给出了预测期（2025-2032 年）内的市场规模（十亿美元）和復合年增长率（%）。
它还重点介绍了各个细分市场的潜在商机，并说明了该市场具有吸引力的投资提案矩阵。
该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要参与者采取的竞争策略的重要见解。
该报告根据以下参数对全球基因表现市场的主要参与者进行了分析：公司概况、产品系列、主要亮点、财务表现和策略。
本报告的研究结果将使负责人和企业经营团队能够就即将推出的产品、类型升级、市场扩张和行销策略做出明智的决策。
本报告的目标受众是全球基因表现市场的各个相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
相关人员可以透过各种用于分析全球基因表现市场的策略矩阵轻鬆做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 16.56 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.20%	2032 Value Projection:	USD 23.61 Bn

Gene expression represents a fundamental biological process through which genetic information encoded in DNA is converted into functional proteins that drive cellular activities and determine organism characteristics. The global gene expression market encompasses a comprehensive range of technologies, reagents, instruments, and services designed to analyze, quantify, and understand gene activity patterns across various biological systems. This rapidly evolving market includes sophisticated analytical platforms such as RNA sequencing, microarrays, quantitative PCR, and next-generation sequencing technologies that enable researchers to decode complex gene regulatory mechanisms.

The market serves diverse applications spanning basic research, drug discovery and development, personalized medicine, agricultural biotechnology, and clinical diagnostics. With increasing investments in genomics research, rising prevalence of genetic disorders, and growing emphasis on precision medicine approaches, the gene expression market has become pivotal in advancing scientific understanding and therapeutic interventions. The integration of artificial intelligence and machine learning algorithms with gene expression analysis platforms is further revolutionizing data interpretation capabilities, enabling researchers to extract meaningful insights from vast genomic datasets and accelerate breakthrough discoveries in life sciences.

Market Dynamics

The global gene expression market is propelled by several key drivers that are fundamentally reshaping the landscape of molecular biology research and clinical applications. The exponential growth in genomics research funding from government agencies and private organizations worldwide serves as a primary catalyst, enabling researchers to invest in advanced gene expression analysis technologies and expand their investigative capabilities. The increasing prevalence of cancer, genetic disorders, and complex diseases necessitates comprehensive gene expression profiling to understand disease mechanisms and develop targeted therapeutic interventions, driving substantial demand for sophisticated analytical platforms.

The rising adoption of personalized medicine approaches, where treatment strategies are tailored based on individual genetic profiles, significantly amplifies the need for accurate gene expression analysis in clinical settings. Additionally, technological advancements in next-generation sequencing, RNA-seq methodologies, and high-throughput screening platforms are enhancing analytical precision and reducing operational costs, making gene expression analysis more accessible to research institutions and healthcare facilities. However, the market faces notable restraints including the high capital investment requirements for advanced gene expression analysis equipment, which can limit adoption among smaller research organizations and emerging market institutions. The complexity of data interpretation and the need for specialized bioinformatics expertise create barriers for organizations lacking adequate technical resources and skilled personnel.

Regulatory compliance requirements and lengthy approval processes for clinical applications can delay market penetration and increase development costs for market participants. Despite these challenges, significant opportunities emerge from the expanding applications of gene expression analysis in agricultural biotechnology, environmental monitoring, and industrial biotechnology sectors. The growing integration of artificial intelligence and machine learning algorithms presents opportunities to develop more sophisticated analytical platforms capable of processing complex genomic datasets and providing actionable insights for researchers and clinicians.

Key Features of the Study

This report provides in-depth analysis of the global gene expression market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global gene expression market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific Inc, Agilent Technologies Inc, Illumina Inc, QIAGEN N.V, Bio-Rad Laboratories Inc, Roche Diagnostics, PerkinElmer Inc, Takara Bio Inc, Promega Corporation, GE Healthcare, Pacific Biosciences of California Inc, Oxford Nanopore Technologies, Fluidigm Corporation, Lonza Group Ltd, and Eurofins Genomics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global gene expression market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gene expression market

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Instruments (PCR Systems, Next-Generation Sequencing Systems, Microarray Scanners, etc.)
- Consumables and Reagents (Kits, Assays and Probes, DNA Chips etc.)
- Software and Services
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Drug Discovery and Development
- Clinical Diagnostics
- Research and Development
Technology Insights (Revenue, USD Bn, 2020 - 2032)
- DNA Microarray
- PCR-Based (qPCR, RT-PCR)
- RNA Sequencing (RNA-Seq)
- Northern Blotting
- Next-Generation Sequencing (NGS)
- Serial Analysis of Gene Expression (SAGE)
Workflow Stage Insights (Revenue, USD Bn, 2020 - 2032)
- Sample Collection and Preparation
- RNA Isolation and Purification
- cDNA Synthesis and Amplification
- Detection and Quantification
- Data Analysis and Interpretation
Sample Type Insights (Revenue, USD Bn, 2020 - 2032)
- Human Samples
- Animal Samples
- Microbial Samples
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Hospitals and Clinical Laboratories
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Thermo Fisher Scientific Inc
- Agilent Technologies Inc
- Illumina Inc
- QIAGEN N.V
- Bio-Rad Laboratories Inc
- Roche Diagnostics
- PerkinElmer Inc
- Takara Bio Inc
- Promega Corporation
- GE Healthcare
- Pacific Biosciences of California Inc
- Oxford Nanopore Technologies
- Fluidigm Corporation
- Lonza Group Ltd
- Eurofins Genomics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Gene Expression Market, By Product Type
- Global Gene Expression Market, By Application
- Global Gene Expression Market, By Technology
- Global Gene Expression Market, By Workflow Stage
- Global Gene Expression Market, By Sample Type
- Global Gene Expression Market, By End User
- Global Gene Expression Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Gene Expression Market, By Product Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Instruments (PCR Systems, Next-Generation Sequencing Systems, Microarray Scanners, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Consumables and Reagents (Kits, Assays and Probes, DNA Chips, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Gene Expression Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Clinical Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Gene Expression Market, By Technology, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
DNA Microarray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
PCR-Based (qPCR, RT-PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
RNA Sequencing (RNA-Seq)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Northern Blotting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Serial Analysis of Gene Expression (SAGE)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Gene Expression Market, By Workflow Stage, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Sample Collection and Preparation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
RNA Isolation and Purification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
cDNA Synthesis and Amplification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Detection and Quantification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Data Analysis and Interpretation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Gene Expression Market, By Sample Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Human Samples
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Animal Samples
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Microbial Samples
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Gene Expression Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hospitals and Clinical Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Gene Expression Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Workflow Stage, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

11. Competitive landscape

Thermo Fisher Scientific Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Illumina Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
QIAGEN N.V
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PerkinElmer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takara Bio Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Promega Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pacific Biosciences of California Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Oxford Nanopore Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fluidigm Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lonza Group Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eurofins Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

12. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

13. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

基因表现市场按产品类型、应用、技术、工作流程步骤、样本类型、最终用户和地区划分

Gene Expression Market, By Product Type, By Application, By Technology, By Workflow Stage, By Sample Type, By End User, By Geography

市场动态

目录

第一章：调查目标和前提条件

第二章市场展望

第三章：市场动态、监理及趋势分析

4. 2020-2032年全球基因表现市场（依产品类型划分）

5. 全球基因表现市场（依应用领域划分），2020-2032年

6. 全球基因表现市场（依技术划分），2020-2032年

7. 2020-2032年全球基因表现市场依工作流程阶段划分

8. 2020-2032年全球基因表现市场（依样本类型划分）

9. 2020-2032年全球基因表现市场（依最终用户划分）

10. 全球基因表现市场（依地区划分），2020-2032年

第十一章竞争格局

第十二章分析师建议

第十三章参考文献与调查方法